Attached files
| file | filename |
|---|---|
| EX-10.21 - FORM OF ESCROW AGREEMENT - Kintara Therapeutics, Inc. | fs12015a7ex10xxi_delmarpharm.htm |
| EX-4.1 - FORM OF WARRANT - Kintara Therapeutics, Inc. | fs12015a7ex4i_delmarpharma.htm |
| EX-10.19 - FORM OF SUBSCRIPTION AGREEMENT (UNITED STATES) - Kintara Therapeutics, Inc. | fs12015a7ex10xix_delmarpha.htm |
| EX-10.20 - FORM OF SUBSCRIPTION AGREEMENT - Kintara Therapeutics, Inc. | fs12015a7ex10xx_delmarpharma.htm |
| S-1/A - AMENDMENT TO FORM S-1/A - Kintara Therapeutics, Inc. | fs12015a7_delmarpharma.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the inclusion in this registration statement on the Form S-1/A Amendment No.7 of DelMar Pharmaceuticals, Inc. of our report dated August 28, 2014 relating to the financial statements of DelMar Pharmaceuticals, Inc., which appears in the Form S-1/A Amendment No.7. We also consent to the references to us under the heading “Experts” in such registration statement.
(signed) PricewaterhouseCoopers LLP
Chartered Accountants
Vancouver, British Columbia
June 22, 2015